180 related articles for article (PubMed ID: 8618963)
1. Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects.
Mickelson JR; Louis CF
Physiol Rev; 1996 Apr; 76(2):537-92. PubMed ID: 8618963
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia and excitation-contraction coupling.
Melzer W; Dietze B
Acta Physiol Scand; 2001 Mar; 171(3):367-78. PubMed ID: 11412150
[TBL] [Abstract][Full Text] [Related]
3. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
4. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
Monnier N; Lunardi J
Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
[TBL] [Abstract][Full Text] [Related]
5. Abnormal human sarcoplasmic reticulum Ca2+ release channels in malignant hyperthermic skeletal muscle.
Fill M; Stefani E; Nelson TE
Biophys J; 1991 May; 59(5):1085-90. PubMed ID: 1651122
[TBL] [Abstract][Full Text] [Related]
6. The action of perchlorate on malignant-hyperthermia-susceptible muscle.
Anderson LC; Fruen BR; Jordan RC; Louis CF; Gallant EM
Pflugers Arch; 1997 Dec; 435(1):91-8. PubMed ID: 9359907
[TBL] [Abstract][Full Text] [Related]
7. Caffeine stimulation of malignant hyperthermia-susceptible sarcoplasmic reticulum Ca2+ release channel.
Shomer NH; Mickelson JR; Louis CF
Am J Physiol; 1994 Nov; 267(5 Pt 1):C1253-61. PubMed ID: 7977689
[TBL] [Abstract][Full Text] [Related]
8. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia.
Gallant EM; Lentz LR
Am J Physiol; 1992 Feb; 262(2 Pt 1):C422-6. PubMed ID: 1539630
[TBL] [Abstract][Full Text] [Related]
9. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
[TBL] [Abstract][Full Text] [Related]
10. Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel.
Tegazzin V; Scutari E; Treves S; Zorzato F
Anesthesiology; 1996 Jun; 84(6):1380-5. PubMed ID: 8669679
[TBL] [Abstract][Full Text] [Related]
11. SR function in malignant hyperthermia.
Nelson TE
Cell Calcium; 1988 Dec; 9(5-6):257-65. PubMed ID: 3066491
[TBL] [Abstract][Full Text] [Related]
12. Voltage-dependent calcium release in human malignant hyperthermia muscle fibers.
Struk A; Lehmann-Horn F; Melzer W
Biophys J; 1998 Nov; 75(5):2402-10. PubMed ID: 9788935
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle excitation-contraction coupling. I. Transverse tubule control of peeled fiber Ca2+-induced Ca2+ release in normal and malignant hyperthermic muscles.
Donaldson SK; Gallant EM; Huetteman DA
Pflugers Arch; 1989 May; 414(1):15-23. PubMed ID: 2726433
[TBL] [Abstract][Full Text] [Related]
14. Abnormal ryanodine receptor channels in malignant hyperthermia.
Fill M; Coronado R; Mickelson JR; Vilven J; Ma JJ; Jacobson BA; Louis CF
Biophys J; 1990 Mar; 57(3):471-5. PubMed ID: 2306496
[TBL] [Abstract][Full Text] [Related]
15. The role of ion-regulatory membrane proteins of excitation-contraction coupling and relaxation in inherited muscle diseases.
Froemming GR; Ohlendieck K
Front Biosci; 2001 Jan; 6():D65-74. PubMed ID: 11145921
[TBL] [Abstract][Full Text] [Related]
16. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
[TBL] [Abstract][Full Text] [Related]
17. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.
Lyfenko AD; Goonasekera SA; Dirksen RT
Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973
[TBL] [Abstract][Full Text] [Related]
18. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
[TBL] [Abstract][Full Text] [Related]
19. Control of calcium in skeletal muscle excitation-contraction coupling: implications for malignant hyperthermia.
Wingertzahn MA; Ochs RS
Mol Genet Metab; 1998 Oct; 65(2):113-20. PubMed ID: 9787103
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ release channels of pigs heterozygous for malignant hyperthermia.
Shomer NH; Mickelson JR; Louis CF
Muscle Nerve; 1995 Oct; 18(10):1167-76. PubMed ID: 7659111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
